Trials / Completed
CompletedNCT01502371
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma (Phase 2; Protocol No. P04223AM3)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 583 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 5 Years – 11 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to demonstrate the dose-related efficacy, by evaluating morning (AM) lung function at the end of the dosing interval (AM pre-dose percent predicted forced expiratory volume in one second \[FEV1\]) across 12 weeks of treatment, of three doses (50 mcg, 100 mcg, and 200 mcg) of Mometasone Furoate (MF) Metered Dose Inhaler (MDI) twice a day (BID) compared with Placebo in children 5 to 11 years of age, inclusive, with persistent asthma. The primary hypothesis of this study is that at least one dose of MF MDI BID increases lung function, defined as a significant increase in percent predicted FEV1, when compared to Placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 25 mcg | MF MDI 25 mcg (per inhalation), 2 puffs BID for 12 weeks |
| DRUG | Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 50 mcg | MF MDI 50 mcg (per inhalation), 2 puffs BID for 12 weeks |
| DRUG | Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 100 mcg | MF MDI 100 mcg (per inhalation), 2 puffs BID for 12 weeks |
| DRUG | Mometasone Furoate (MF) Dry Powder Inhaler (DPI), 100 mcg | MF DPI 100 mcg (per inhalation), 1 puff QD for 12 weeks |
| DRUG | Placebo Metered Dose Inhaler (MDI) | Placebo MDI, 2 puffs BID for 12 weeks |
| DRUG | Placebo Dry Powder Inhaler (DPI) | Placebo DPI, 1 puff QD for 12 weeks |
Timeline
- Start date
- 2012-01-25
- Primary completion
- 2015-01-29
- Completion
- 2015-01-29
- First posted
- 2011-12-30
- Last updated
- 2024-06-17
- Results posted
- 2015-10-06
Source: ClinicalTrials.gov record NCT01502371. Inclusion in this directory is not an endorsement.